NO971672D0 - Benzofuran og benzokondenserte forbindelser, deres fremstilling og deres anvendelse som leukotrien B4(LTB4)antagonister - Google Patents

Benzofuran og benzokondenserte forbindelser, deres fremstilling og deres anvendelse som leukotrien B4(LTB4)antagonister

Info

Publication number
NO971672D0
NO971672D0 NO971672A NO971672A NO971672D0 NO 971672 D0 NO971672 D0 NO 971672D0 NO 971672 A NO971672 A NO 971672A NO 971672 A NO971672 A NO 971672A NO 971672 D0 NO971672 D0 NO 971672D0
Authority
NO
Norway
Prior art keywords
ltb4
leukotriene
benzofuran
benzo
antagonists
Prior art date
Application number
NO971672A
Other languages
English (en)
Other versions
NO971672L (no
Inventor
Mark A Dombroski
Kevin Koch
Anthony D Piscopio
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO971672D0 publication Critical patent/NO971672D0/no
Publication of NO971672L publication Critical patent/NO971672L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
NO971672A 1994-10-13 1997-04-11 Benzofuran og benzokondenserte forbindelser, deres fremstilling og deres anvendelse som leukotrien B4(LTB4)antagonister NO971672L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32287694A 1994-10-13 1994-10-13
PCT/IB1995/000401 WO1996011920A1 (en) 1994-10-13 1995-05-26 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists

Publications (2)

Publication Number Publication Date
NO971672D0 true NO971672D0 (no) 1997-04-11
NO971672L NO971672L (no) 1997-06-11

Family

ID=23256829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971672A NO971672L (no) 1994-10-13 1997-04-11 Benzofuran og benzokondenserte forbindelser, deres fremstilling og deres anvendelse som leukotrien B4(LTB4)antagonister

Country Status (23)

Country Link
US (2) US6051601A (no)
EP (1) EP0785930A1 (no)
JP (1) JP2983295B2 (no)
KR (1) KR100232341B1 (no)
CN (1) CN1160399A (no)
AU (1) AU696890B2 (no)
BR (1) BR9504385A (no)
CA (1) CA2201742A1 (no)
CO (1) CO4480024A1 (no)
CZ (1) CZ111797A3 (no)
FI (1) FI971524A0 (no)
HU (1) HUT77515A (no)
IL (1) IL115529A0 (no)
MX (1) MX9702731A (no)
NO (1) NO971672L (no)
NZ (1) NZ285156A (no)
PE (1) PE10897A1 (no)
PL (1) PL319688A1 (no)
RU (1) RU2128655C1 (no)
TR (1) TR199501270A2 (no)
TW (1) TW304941B (no)
WO (1) WO1996011920A1 (no)
ZA (1) ZA958597B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2265043C (en) * 1996-09-16 2003-01-14 Pfizer Inc. Processes and intermediates for preparing substituted chromanol derivatives
EP0961617A4 (en) * 1996-12-13 2002-08-07 Lilly Co Eli LEUKOTRINE ANTAGONISTS FOR TREATING FOCAL BRAIN CHEMISTRY
IL128731A0 (en) * 1998-03-12 2000-01-31 Pfizer Prod Inc Method of preventing allograft rejection
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
CA2433516A1 (en) * 2001-01-30 2002-08-08 Keith Michael Devries Processes for preparing chromanylbenzoic acids
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
CA2485537A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation
RU2007101510A (ru) * 2004-07-22 2008-08-27 Фармаци Корпорейшн (US) Композиции для лечения воспаления и боли с использованием комбинации селективного ингибитора сох-2 и антагониста рецептора ltb4
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
BRPI0519013A2 (pt) * 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
WO2006093548A1 (en) 2005-02-25 2006-09-08 Galileo Pharmaceuticals, Inc. Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
JP2009536953A (ja) 2006-05-11 2009-10-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃｅｔｐ阻害剤としての１，２，３，４−テトラヒドロ−キノリン誘導体
WO2007134149A2 (en) 2006-05-11 2007-11-22 Janssen Pharmaceutica N.V. 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
EP2344458A1 (en) 2008-09-11 2011-07-20 Pfizer Inc. Heteroaryls amide derivatives and their use as glucokinase activators
EA018894B1 (ru) * 2009-03-11 2013-11-29 Пфайзер Инк. N,n-диметил-5-(2-метил-6-((5-метилпиразин-2-ил)карбамоил)бензо-фуран-4-илокси)пиримидин-2-карбоксамид, используемый в качестве активатора глюкокиназы, и содержащая его фармацев-тическая композиция
EP2814494B1 (en) 2012-02-14 2019-08-21 Children's Hospital Medical Center Use of small molecule inhibitors targeting the interaction between rac gtpase and p67 (phox)
CN102920692A (zh) * 2012-10-25 2013-02-13 中国人民解放军第二军医大学 (e)-2-(1-羟基-4-环己酮)乙基咖啡酸酯在制备防治类风湿关节炎的药物中的应用
WO2016149099A1 (en) 2015-03-13 2016-09-22 Forma Therapeutics, Inc. Alpha-cinnamide compounds and compositions as hdac8 inhibitors
TW201711999A (zh) 2015-09-03 2017-04-01 佛瑪治療公司 ﹝６，６﹞稠合雙環組蛋白脫乙醯基酶８（ｈｄａｃ８）抑制劑
EP3383388B1 (en) 2015-11-30 2021-04-14 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
EP3383389B1 (en) 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
WO2017095725A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
EP3383868B1 (en) 2015-11-30 2022-10-05 Merck Sharp & Dohme LLC Aryl sulfonamides as blt1 antagonists
US20190216790A1 (en) * 2016-10-13 2019-07-18 The Regents Of The University Of California Methods for Treating Pruritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
CA2019335C (en) * 1989-06-27 2000-08-01 Mitoshi Konno Phenylalkan (en)oic acids
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5051438A (en) * 1990-05-16 1991-09-24 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
WO1993015066A1 (en) * 1992-01-23 1993-08-05 Pfizer Inc. Benzopyran and related ltb4 antagonists

Also Published As

Publication number Publication date
CZ111797A3 (cs) 1998-07-15
KR970706270A (ko) 1997-11-03
PE10897A1 (es) 1997-04-21
CA2201742A1 (en) 1996-04-25
BR9504385A (pt) 1997-05-27
AU2416795A (en) 1996-05-06
AU696890B2 (en) 1998-09-24
NZ285156A (en) 1999-01-28
ZA958597B (en) 1997-04-14
CN1160399A (zh) 1997-09-24
PL319688A1 (en) 1997-08-18
NO971672L (no) 1997-06-11
WO1996011920A1 (en) 1996-04-25
JP2983295B2 (ja) 1999-11-29
EP0785930A1 (en) 1997-07-30
US6133286A (en) 2000-10-17
HUT77515A (hu) 1998-05-28
RU2128655C1 (ru) 1999-04-10
IL115529A0 (en) 1996-01-19
US6051601A (en) 2000-04-18
CO4480024A1 (es) 1997-07-09
KR100232341B1 (ko) 2000-07-01
FI971524A (fi) 1997-04-11
JPH09512035A (ja) 1997-12-02
MX9702731A (es) 1997-06-28
TR199501270A2 (tr) 1996-06-21
TW304941B (no) 1997-05-11
FI971524A0 (fi) 1997-04-11

Similar Documents

Publication Publication Date Title
NO971672D0 (no) Benzofuran og benzokondenserte forbindelser, deres fremstilling og deres anvendelse som leukotrien B4(LTB4)antagonister
NO971673D0 (no) Benzopyran og benzokondenserte forbindelser, deres fremstiling og anvendelse som leukotrien B4 (LTB4) antagonister
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO20000185L (no) Kondenserte 1,2,4-tiadiazinderivater, deres fremstilling og anvendelse
NO954369L (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO20005411D0 (no) Antipicornavirusforbindelser, deres fremstilling og anvendelse
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO177751C (no) Piperidinsubstituerte polysiloksanforbindelser, deres fremstilling og anvendelse
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
DE69728515D1 (de) Umkehrbare, medienunabhängige Schnittstellenschaltung
DK228385A (da) 1-heteroaryl-4-aryl-pyrazolin-5-oner, deres fremstilling og anvendelse som mikrobiocider
NO955305L (no) Optisk aktive benzotiepinderivater, deres fremstilling og anvendelse
NO884223D0 (no) Leukotrien ltd4-og ltb4-antagonister og fremgangsmaate for deres fremstilling.
NO20004271D0 (no) Benzylpiperazinyl- og benzylpiperidinyl etanonderivater, deres fremstilling og deres anvendelse som dopamin D4 reseptorantagonister
NO903978L (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
DK390889D0 (da) Substituerede dioxolaner, deres fremstilling og anvendelse som mikrobiocider samt ved fremgangsmaaden anvendelige mellemprodukter og disses fremstilling
NO903677D0 (no) Utfelt amorf silika eller silikat som oppmalingshjelp forfiskekjoett eller fiskemat.
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
HUP0104510A3 (en) Benzofuran derivatives, their preparation and use
DK1010689T3 (da) Substituerede cycloheptener, deres fremstilling og anvendelse
DK0741686T3 (da) Hidtil ukendte leukotrien-B4-derivater, fremgangsmåder til fremstilling heraf og deres anvendelse som lægemiddel
LV11954A (lv) 14-alfa,17-alfa-C2-tiltina saites 19-nor-progesterona atvasinajumi
NO910590D0 (no) Hydratiserte silikater, fremgangsmaate for deres fremstilling og anvendelse.
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application